Date | Title | Description | Source |
24.04.2024 | Pharma exports rise around 10% to $27.9 billion, US biggest ... | - | business-s... |
19.04.2024 | How will Israel's attack on Iran impact the stock market, cr... | - | business-s... |
15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - | labusiness... |
15.04.2024 | Israel outweighs Iran in trade with India since 2019, shows ... | - | business-s... |
11.04.2024 | Over 6,000 Indian workers to reach Israel by May to help lab... | - | business-s... |
03.04.2024 | Biden touts inhaler price drops with Bernie Sanders: "F... | Sen. Bernie Sanders and President Biden joined forces Wednesday at the White House, championing the ... | cbsnews.co... |
29.03.2024 | Health | Experts say Medicaid rebate change is behind inhale... | Lauren Clason | (TNS) CQ-Roll Call
A recent tweak to a Medicaid formula could be behind the shake-up... | dailycamer... |
13.03.2024 | Contraceptives Market Growth Soars: Aiming for $50.6 Billion... | Contraceptives Market Report
WILMINGTON, DELAWARE, UNITED STATES, March 13, 2024 /EINPresswire.com/ ... | einpresswi... |
13.03.2024 | Pregabalin Market to Reach $2.2Billion Globally, By 2032 at ... | - | globenewsw... |
12.03.2024 | Opioid Use Disorder Market to Reach USD 6.15 Billion by 2030... | Opioid Use Disorder (OUD) Market
Opioid Use Disorder Market Analysis, Industry Trends and Growth Out... | einpresswi... |
09.03.2024 | CVS Pharmacy to Settle for $10 Million for Alaska Opioid Cri... | March 8, 2024
(Anchorage, AK) – The State of Alaska filed a complaint and consent judgment Thursda... | einpresswi... |
06.03.2024 | Capecitabine Global Market Report 2024 | - | globenewsw... |
04.03.2024 | Esomeprazole Market Size Worth $3.22 Billion by 2033; Escala... | - | globenewsw... |
30.06.2023 | Teva Issues Voluntary Nationwide Recall of One Lot of IDArub... | COMPANY ANNOUNCEMENT This recall has been completed and FDA has terminated this recall.
When a compa... | einpresswi... |
07.06.2023 | Attorney General Ford Announces $193 Million Settlement with... | Carson City, NV – Today, Nevada Attorney General Aaron D. Ford announced that Nevada will receive ap... | einpresswi... |
17.11.2022 | Rimidi Showcases New Module for Respiratory Disease Manageme... | Digital therapeutics, like the Digihaler® platform, are making new data available to clinicians in t... | prweb.com/... |
02.09.2022 | Meet the Founder: To tackle stress, Big Pharma veteran Rache... | Some years ago, the World Health Organization (WHO) called stress “the health epidemic of the 21st c... | agfunderne... |
27.07.2022 | $4.4 Billion Opioid Settlement Gives Teva Stock a Boost | After almost a decade of legal battles, the extraordinary complicated tangle of lawsuits seeking to ... | barrons.co... |
23.05.2022 | Teva Issues Voluntary Nationwide Recall of One Lot of Anagre... | COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA ... | einpresswi... |
10.05.2022 | Teva Publishes 2021 ESG Progress Report, Showcasing Further ... | Environmental, Social and Governance (ESG) efforts integrated into business strategy with strengthen... | esgnews.co... |
22.03.2022 | Teva reaches $100M settlement with Rhode Island for dec... | Kåre Schultz, the top dog at Teva Pharmaceuticals, said last month on a Q4 call that the pharm... | endpts.com... |
09.02.2022 | Teva Pharmaceutical Industries : Reports Fourth Quarter and ... | Teva Reports Fourth Quarter and Full Year 2021 Financial Results
TEL AVIV, Israel--(BUSINESS WIRE)--... | marketscre... |
06.01.2022 | Seattle Children's collaboration to dive into cell th... | A cell and gene therapy company is extending its collaboration with Seattle Children’s H... | endpts.com... |
25.11.2021 | Quantum Genomics : Quantum Genomics signs an exclusive licen... | Press release
Paris, November 25, 2021
Quantum Genomics signs an exclusive license agreement with Te... | marketscre... |
27.10.2021 | Teva Reports Third Quarter 2021 Financial Results - Form 8-K | Teva Reports Third Quarter 2021 Financial Results
Revenues of $3.9 billion
GAAP diluted EPS of $0.26... | marketscre... |
19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | FN Media Group Presents Oilprice.com Market Commentary
LONDON, Oct. 19, 2021 /PRNewswire/ -- Accordi... | salamancap... |
19.10.2021 | Is This The Most Exciting Medical Breakthrough Of The Decade | LONDON, Oct. 19, 2021 /PRNewswire/ -- According to Google's Health boss David Feinberg... over one b... | salamancap... |
28.07.2021 | Teva Pharmaceutical Industries : Reports Second Quarter 2021... | Teva Reports Second Quarter 2021 Financial Results
Revenues of $3.9 billion
GAAP diluted EPS of $0.1... | marketscre... |
23.06.2021 | Teva Pharmaceutical Industries : Announces Its Launch of the... | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),... | marketscre... |
17.05.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical ... | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),... | marketscre... |
04.05.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical ... | Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),... | marketscre... |
23.04.2021 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical ... | Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TA... | marketscre... |
07.12.2020 | After coronavirus vaccine success, is Israel’s MigVax still ... | Despite encouraging news that at least three vaccines provide some protection against COVID-19, lead... | timesofisr... |
27.08.2020 | Generic drugmaker Teva indicted in alleged price-fixing cons... | “Today’s charge reaffirms that no company is too big to be prosecuted for its role in conspiracies t... | medcitynew... |
17.03.2020 | Generic ‘identity’ gets lost when companies juggle both gene... | We think we know generic drug companies. They challenge patents held by brand firms. They litigate v... | statnews.c... |
26.11.2019 | Merck adds another OK to Keytruda scoreboard; Ardelyx,... | → Merck‘s anti-PD-1 blockbuster, Keytruda, is racking up win after win. The newest jewel to t... | endpts.com... |
15.09.2018 | Teva gets a badly needed win: FDA OKs their runner-up CG... | Kåre Schultz
The FDA has come through with a delayed OK for Teva’s new migraine drug. And this on... | endpts.com... |
25.07.2018 | Philadelphia’s digital health ecosystem takes shape | In an interview with Tom Olenzak, Managing Director for Independence Blue Cross’s Strategic Innovati... | medcitynew... |
06.02.2018 | Allergan just got one step closer to approval for its migrai... | Johan Swanepoel/Shutterstock
A human brain and its millions of small nerves
Advertisement
There's a ... | businessin... |
10.10.2017 | Pontifax AgTech Closes Fund I on $105m | Pontifax Food and Agriculture Technology Fund (Pontifax AgTech) has closed its first fund on $105 mi... | agfunderne... |
19.09.2017 | Term Sheet — Tuesday, September 19 | VCs VERSUS ICOs
Companies have raised more than $1.7 billion through initial coin offerings this yea... | fortune.co... |
14.09.2017 | Term Sheet — Thursday, September 14 | UNICORN STATUS
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see Fr... | fortune.co... |
02.08.2017 | Teva loses ‘buyer’s remorse’ lawsuit over a deal to buy a Me... | A New York State court judge tossed a widely publicized lawsuit in which Teva Pharmaceuticals accuse... | statnews.c... |
26.04.2017 | Buzz: Teva Chairman Sol Barer is getting busy with a top... | Credit: Flash 90 2013
Rumors about big changes in the works for Teva are reaching a fever pitch.... | endpts.com... |
03.04.2017 | In a first for deuterated drugs, FDA (finally) OKs Teva... | Ten months after the FDA put Teva’s would-be blockbuster deutetrabenazine on hold after raisin... | endpts.com... |
06.02.2017 | Teva CEO stands down during troubled times | The company disclosed on Monday that Vigodman had resigned from the top job “effective immediately.”... | medcitynew... |
04.12.2016 | Verily launches clever new spoon that compensates for disabi... | Level is the brainchild of Anupam Pathak who parlayed a PhD in mechanical engineering and an SBIR gr... | medcitynew... |
20.09.2016 | Pridopidine is still a mess in latest Huntington’s stu... | Six years ago a Danish company called NeuroSearch enjoyed a few days in the sun when it said it... | endpts.com... |
12.09.2016 | With small RetroSense deal, Allergan hoping for big win | RP is a group of congenital retinal diseases driven by mutations in the rhodopsin gene. The disease ... | medcitynew... |
25.02.2016 | With New Partnership, Propeller Health To Make Inhaler From ... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Propeller Health knows a thing or t... | xconomy.co... |
27.07.2015 | Following Its $560M Acquisition, NU Drug Startup Naurex Laun... | This weekend Naurex, an Evanston-based biopharma company that creates depression-treating drugs, was... | bizjournal... |
03.06.2015 | Teva Pharmaceuticals invests “tens of millions” in telemedic... | “Teva is committed to attaining a significant presence in the rapidly growing electronic medicine fi... | medcitynew... |
06.05.2015 | Teva snags Auspex Pharmaceutical for $3.5B, PTC acquires Col... | PTC announced it has signed a definitive agreement to acquire ColdLight, a visionary in big data mac... | medcitynew... |
25.03.2015 | Stealth neuroscience startup Ovid Therapeutics raises $5M fo... | The article continues:
Levin is set to disclose more about the company in the next few weeks but for... | medcitynew... |
30.01.2015 | Teva, Philips pouring $25M into new Israeli health tech incu... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems stri... | medcitynew... |
15.01.2015 | The healthcare incentives driving MediSafe's adoption | MediSafe CEO Omri Shor on the Israeli and Boston-based pill-reminder startup's $6 million raise
In a... | vator.tv/n... |
16.10.2014 | Venture firm Canaan Partners raises $675 million more; plans... | The company’s had a dozen exits in the same number of months, many of which high profile – portfolio... | medcitynew... |
10.09.2014 | Xenon pitches Genentech, Teva 'extreme genetics' ties as it ... | Xenon Pharmaceuticals has gone 8 long years since its last equity raise, relying on a slate of partn... | fiercebiot... |
09.05.2013 | Entrepreneur recuperating from heart surgery wins hackathon ... | “After that, I slept for two days,” he told MedCity News in a phone interview.
Quillen is a veteran ... | medcitynew... |
10.05.2012 | Propofol drug shortages: The economic problem of a generic i... | Three years ago, propofol was available from three companies. Besides Hospira, Teva Pharmaceutical a... | medcitynew... |
24.04.2012 | FDA finalizes Cetero’s time frame for clinical trials requir... | Cetero focuses on early phase clinical research. The FDA’s Cetero inquiry became public last July af... | medcitynew... |
01.02.2012 | Generic competitor to GSK AIDS drug Epzicom gets tentative F... | Epzicom is GSK’s top-selling HIV treatment and generated $860 million in 2010 sales, $325 million in... | medcitynew... |
10.01.2012 | iBio seeks to raise $10 million for plant-based vaccine prod... | Among the company’s pipeline of vaccines and biotherapeutics are vaccines for H1N1 influenza, or swi... | medcitynew... |
08.12.2011 | Novartis gets FDA warning letter for N.C., Colorado and Queb... | Novartis, headquartered in Basel, Switzerland, has had at least three years notice for some of the p... | medcitynew... |
05.12.2011 | Senators question Pfizer Lipitor deals, Ranbaxy gets FDA app... | Among Pfizer’s efforts are offering patients $4 co-pay cards for Lipitor at a local participating ph... | medcitynew... |
08.11.2011 | Teva, Ferring boost Antares Pharma product sales | Antares Pharma product sales soared 41 percent in the first nine months of 2011 to $5.8 million, hel... | medcitynew... |
02.11.2011 | Par Pharmaceuticals builds up generics business | Par Pharmaceuticals (NYSE: PRX) revved up its generic drugs category with two substantial acquisitio... | medcitynew... |
27.10.2011 | 5 mistakes companies make launching drugs, medical devices | Understand your customers. Particularly with smaller companies that do not have the resources of Big... | medcitynew... |
26.10.2011 | Biogen Idec preps for FDA filing after strong trial results ... | Weston, Massachusetts-based Biogen Idec already makes its MS drugs Tysabri and Avonex at its facilit... | medcitynew... |
25.10.2011 | Biotech 2011: Teva, Merck directors share views of biopharma... | He called for companies to diversify, through research and, to some extent, by acquiring or partneri... | medcitynew... |
20.06.2011 | GSK HIV drug pipeline sees boost as partner Concert steers t... | The identification of a lead drug for treating HIV could be even bigger news for a GSK HIV program t... | medcitynew... |
02.06.2011 | Alzheimer’s disease drug Aricept faces rising tide of generi... | Aricept’s patents expired last November and the first drugs company to market an Aricept generic was... | medcitynew... |
31.05.2011 | GSK’s HIV drug combivir to face generic from Teva | Combivir now falls under the umbrella of ViiV Healthcare, a company formed jointly by GSK and Pfizer... | medcitynew... |
22.01.2008 | Life sciences briefing: Tuesday, Jan. 22, 2007 | TODAY’S HEADLINES:
Teva acquires protein-therapeutic maker CoGenesys for $400M (release)
ViewRay tak... | venturebea... |
- | Biotech 2011: Teva, Merck directors share views of biopharma... | Kevin Buchi, the head of global branded products for Teva Pharmaceutical Industries (NASDAQ: TEVA), ... | medcitynew... |
- | Teva snags Auspex Pharmaceutical for $3.5B, PTC acquires Col... | TOP STORIES
Teva has completed its $3.5-billion purchase of Auspex Pharmaceuticals – still keeping a... | medcitynew... |
- | Teva CEO stands down during troubled times | Israel’s Teva Pharmaceuticals is looking fragile as CEO Erez Vigodman steps down and the company los... | medcitynew... |
- | Stealth neuroscience startup Ovid Therapeutics raises $5M fo... | Stealth New York-based startup Ovid Therapeutics just raised $5 million, according to a regulatory f... | medcitynew... |
- | Par Pharmaceuticals builds up generics business | Par Pharmaceuticals (NYSE: PRX) revved up its generic drugs category with two substantial acquisitio... | medcitynew... |
- | With small RetroSense deal, Allergan hoping for big win | Allergan’s recent deal for gene therapy company RetroSense Therapeutics, based in Ann Arbor, Michiga... | medcitynew... |
- | Propofol drug shortages: The economic problem of a generic i... | Propofol might best be known as the anesthetic Michael Jackson used inappropriately as a sleeping ai... | medcitynew... |
- | Entrepreneur recuperating from heart surgery wins hackathon ... | Entrepreneurs face plenty of stress pitching a new idea to a potential customer. But most don’t have... | medcitynew... |
- | Alzheimer’s disease drug Aricept faces rising tide of generi... | The patent wall protecting Eisai‘s (TYO:4523) blockbuster Alzheimer’s disease drug Aricept is crumbl... | medcitynew... |
- | GSK’s HIV drug combivir to face generic from Teva | GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a gene... | medcitynew... |
- | Biogen Idec preps for FDA filing after strong trial results ... | Biogen Idec (NASDAQ:BIIB) is on track to add a third multiple sclerosis therapy to its portfolio — o... | medcitynew... |
- | iBio seeks to raise $10 million for plant-based vaccine prod... | iBio (NYSE:IBIO) is seeking to raise $10 million for its plant-based vaccine production in a public ... | medcitynew... |
- | FDA Says ADHD Med Adderall Is in Short Supply | THURSDAY, Oct. 13, 2022 (HealthDay News) -- People with attention-deficit/hyperactivity disorder (AD... | salamancap... |
- | 5 mistakes companies make launching drugs, medical devices | So, you not only come up with a great medical device or drug that will improve or save lives, you sp... | medcitynew... |
- | Generic drugmaker Teva indicted in alleged price-fixing cons... | The Department of Justice has indicted the world’s largest generic drug company, accusing it of part... | medcitynew... |
- | Are biosimilars the next frontier in drug development? | A conversation on reducing costs
Biological products are the fastest growing class of therapeutic pr... | statnews.c... |
- | Venture firm Canaan Partners raises $675 million more; plans... | Menlo Park venture firm Canaan Partners just raised $675 million for its tenth fund – with plans to ... | medcitynew... |
- | FDA finalizes Cetero’s time frame for clinical trials requir... | Cetero Research, the clinical research organization that fell under a U.S. Food and Drug Administrat... | medcitynew... |
- | Teva, Philips pouring $25M into new Israeli health tech incu... | Israeli drugmaker Teva Pharmaceuticals and the healthcare arm of Netherlands-based Royal Philips hav... | medcitynew... |
- | Verily launches clever new spoon that compensates for disabi... | The Liftware device from Verily that makes eating without spilling easier
People with physical disab... | medcitynew... |
- | Senators question Pfizer Lipitor deals, Ranbaxy gets FDA app... | Three U.S. senators are raising questions with Pfizer (NYSE:PFE) over its deal making for its mega-b... | medcitynew... |
- | Teva, Ferring boost Antares Pharma product sales | Antares Pharma product sales soared 41 percent in the first nine months of 2011 to $5.8 million, hel... | medcitynew... |
- | Generic competitor to GSK AIDS drug Epzicom gets tentative F... | Generic competition for GlaxoSmithKline (NYSE:GSK) AIDS drug Epzicom is on its way around the world,... | medcitynew... |
- | GSK HIV drug pipeline sees boost as partner Concert steers t... | A strategic alliance GlaxoSmithKline (NYSE:GSK) entered into with partner Concert Pharmaceuticals no... | medcitynew... |
- | Philadelphia’s digital health ecosystem takes shape | This article is sponsored by the CEO Council for Growth, an initiative of the Chamber of Commerce fo... | medcitynew... |
- | Teva Pharmaceuticals invests “tens of millions” in telemedic... | Israeli generics giant Teva Pharmaceuticals is investing “tens of millions” of dollars into telemedi... | medcitynew... |